Daratumumab, DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE
CT-P44 3.1
Phase 3 small_molecule active
Quick answer
Daratumumab, DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE for Refractory or Relapsed Multiple Myeloma is a Phase 3 program (small_molecule) at Celltrion Healthcare Hungary Kft. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celltrion Healthcare Hungary Kft.
- Indication
- Refractory or Relapsed Multiple Myeloma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active